233 related articles for article (PubMed ID: 19172482)
1. Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.
Ahlenstiel G; Woitas RP; Iwan A; Nattermann J; Feldmann G; Rockstroh JK; Oldenburg J; Kupfer B; Sauerbruch T; Spengler U
Immunol Invest; 2009; 38(1):1-13. PubMed ID: 19172482
[TBL] [Abstract][Full Text] [Related]
2. Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.
Ahlenstiel G; Woitas RP; Iwan A; Nattermann J; Feldmann G; Rockstroh JK; Oldenburg J; Kupfer B; Sauerbruch T; Spengler U
Immunol Invest; 2009; 38(3-4):284-96. PubMed ID: 19811439
[TBL] [Abstract][Full Text] [Related]
3. CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?
Ahlenstiel G; Woitas RP; Rockstroh J; Spengler U
J Antimicrob Chemother; 2004 Jun; 53(6):895-8. PubMed ID: 15128728
[TBL] [Abstract][Full Text] [Related]
4. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
[TBL] [Abstract][Full Text] [Related]
5. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
[TBL] [Abstract][Full Text] [Related]
6. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
[TBL] [Abstract][Full Text] [Related]
7. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.
Leroux-Roels G; Esquivel CA; DeLeys R; Stuyver L; Elewaut A; Philippé J; Desombere I; Paradijs J; Maertens G
Hepatology; 1996 Jan; 23(1):8-16. PubMed ID: 8550052
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
Semmo N; Krashias G; Willberg C; Klenerman P
J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
[TBL] [Abstract][Full Text] [Related]
9. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V
J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure.
Bes M; Esteban JI; Casamitjana N; Piron M; Quer J; Cubero M; Puig L; Guardia J; Sauleda S
Transfusion; 2009 Jul; 49(7):1296-305. PubMed ID: 19222816
[TBL] [Abstract][Full Text] [Related]
11. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
[TBL] [Abstract][Full Text] [Related]
12. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
[TBL] [Abstract][Full Text] [Related]
13. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes.
Woitas RP; Lechmann M; Jung G; Kaiser R; Sauerbruch T; Spengler U
J Immunol; 1997 Jul; 159(2):1012-8. PubMed ID: 9218624
[TBL] [Abstract][Full Text] [Related]
14. CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.
Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Schirin-Sokhan R; Gartung C; Lorenzen J; Matern S; Lammert F
J Mol Med (Berl); 2004 Jan; 82(1):64-9. PubMed ID: 14673528
[TBL] [Abstract][Full Text] [Related]
15. Blocking of interleukin-10 receptor--a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus.
Rigopoulou EI; Abbott WG; Haigh P; Naoumov NV
Clin Immunol; 2005 Oct; 117(1):57-64. PubMed ID: 16006191
[TBL] [Abstract][Full Text] [Related]
16. Study of hepatitis C virus specific immune responses in anti-HCV positive patients without hepatitis C viremia.
Yao P; Hu X; Hu D
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):227-30. PubMed ID: 11498684
[TBL] [Abstract][Full Text] [Related]
17. Impact of HIV on host-virus interactions during early hepatitis C virus infection.
Danta M; Semmo N; Fabris P; Brown D; Pybus OG; Sabin CA; Bhagani S; Emery VC; Dusheiko GM; Klenerman P
J Infect Dis; 2008 Jun; 197(11):1558-66. PubMed ID: 18419344
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.
Nattermann J; Zimmermann H; Iwan A; von Lilienfeld-Toal M; Leifeld L; Nischalke HD; Langhans B; Sauerbruch T; Spengler U
Hepatology; 2006 Oct; 44(4):945-54. PubMed ID: 17006905
[TBL] [Abstract][Full Text] [Related]
19. ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producing peripheral blood lymphocytes in infected humans with and without cirrhosis.
Anthony DD; Post AB; Valdez H; Peterson DL; Murphy M; Heeger PS
Clin Immunol; 2001 May; 99(2):232-40. PubMed ID: 11318595
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection.
Thurairajah PH; Hegazy D; Chokshi S; Shaw S; Demaine A; Kaminski ER; Naoumov NV; Cramp ME
J Infect Dis; 2008 Dec; 198(12):1749-55. PubMed ID: 18959498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
